Zhejiang Conba Pharmaceutical Co (SHSE:600572) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600572 Zhejiang Conba Pharmaceutical Co Ltd SHSE:600572
71 GF Score
Price ¥4.32
GF Value ¥5.51
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Zhejiang Conba Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:600572 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Conba Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Conba Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Conba Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Zhejiang Conba Pharmaceutical Co's Short Interest falls into.


SHSE:600572
71GF Score
Zhejiang Conba Pharmaceutical Co Ltd SHSE:600572
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Conba Pharmaceutical Co (SHSE:600572) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Conba Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥4.32 is trading 21.6% below its estimated GF Value™ of ¥5.51. GuruFocus considers Zhejiang Conba Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600572:

  • Short Interest:
  • GF Value™: ¥5.51 vs. price of ¥4.32 (21.6% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Conba Pharmaceutical Co Business Description

Address No. 568 Binkang Road, New and High-Technology Development Zone, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
Zhejiang Conba Pharmaceutical Co Ltd operates as a pharmaceutical company in China. It offers traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. It provides its products under the Conba, Prostate Plus, Zhenshiming, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, and Omeprazole names.
71GF Score

Get the complete analysis for SHSE:600572

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.32
Price
¥5.51
GF Value